Vernalis PLC Share News (VER)

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

Sector movers: Weak results, outlook from Glaxo sink pharma stocks

A slump in the share price of GlaxoSmithKline dragged the pharmaceuticals and biotechnology sector into the red on Wednesday as the drugmaker disappointed with a drop in quarterly sales and its full-year outlook. The company announced at midday that it has slashed its 2014 outlook as it reported a

Vernalis Third Cough Cold Product Achieves Proof-of-Concept

Tuesday broker round-up UPDATE

Abcam: N+1 Singer places both its target price (prev.: 346p) and its sell recommendation under review. Amiad Water Systems: Oriel lowers target price from 350p to 340p and retains a buy recommendation. Ashmore Group: Espirito Santo ups target price from 371p to 404p, while downgrading to neutral.

Monday broker round-up UPDATE

Balfour Beatty: Berenberg lowers target price from 290p to 280p and retains a buy recommendation. UBS lowers target price from 230p to 225p and keeps a neutral rating. Barclays: Citi lowers target price from 305p to 300p and keeps its sell recommendation. Clinigen: Investec cuts target price from

UK BROKER RATINGS: HSBC Cuts Antofagasta To Neutral And Target 13%

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
BERENBERG INITIATES CARNIVAL PLC WITH 'BUY' - TARGET 3,000 PENCE
----------
UBS RAISES ASTRAZENECA PRICE TARGET TO 4

STOCKS NEWS EUROPE-UK small caps slide lower

The FTSE Small Cap Index is down by 0.5 percent while the junior-listed FTSE AIM All Share Index retreats by 1.1 percent, broadly tracking a 0.8 percent drop on the blue-chip index while the mid-caps fall by 1.4 percent. Pharmaceuticals and biotech company Vernalis slips by 2.4 percent to

Tuesday broker round-up UPDATE

API Group: Numis lowers target price from 90p to 84p, while upgrading from add to buy. Cranswick: Investec increases target price from 1315p to 1390p retaining its buy recommendation. Daisy Group: FinnCap moves target price from 175p to 185p and retains a hold recommendation. DP World: Nomura rai

STOCKS NEWS EUROPE-AIM index slips, Vernalis outperforms

Junior-listed AIM shares slip 0.1 percent, lagging the FTSE Small Cap index, up 0.2 percent, along with the mid-caps and the blue chips, up 0.4 percent and 0.6 percent respectively. Pharmaceutical firm Vernalis climbs nearly 3 percent after it unveils full-year results ahead of market expec

Tuesday broker round-up UPDATE

African Barrick Gold: Deutsche Bank raises target price from 240p to 310p and keeps a hold recommendation. African Minerals: Deutsche Bank lowers target price from 399p to 382p, while its buy recommendation is kept. Allergy Therapeutics: Panmure Gordon ups target price from 16p to 25p and retains

Vernalis beats full-year targets, positive on outlook

- Full-year ahead of expectations - Cold programme progressing well - Extremely positive outlook for 2014 and beyond Biotech specialist Vernalis said its full-year performance was ahead of market expectations and the outlook for 2014 and beyond is 'extremely positive'. The pharmaceutical company